NCT02414282View on ClinicalTrials.gov

F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E)

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 31, 2015

Primary Completion Date

October 20, 2020

Study Completion Date

October 20, 2020

Conditions
Alzheimer DiseaseProgressive Posterior Cortical Dysfunction (PPCD)
Interventions
DRUG

F 18 T807

Participants will receive a single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807. For those who cannot tolerate the full exam, participants will receive single intravenous bolus injection of approximately 6.5-10mCi (240-370MBq) of F 18 T807.

Trial Locations (1)

63110

Washington University School of Medicine, St Louis

All Listed Sponsors
lead

Tammie L. S. Benzinger, MD, PhD

OTHER

NCT02414282 - F 18 T807 Tau PET Imaging of Progressive Posterior Cortical Dysfunction (IND 123119, Protocol E) | Biotech Hunter | Biotech Hunter